Evolving Indications for Liver Transplantation for Hepatocellular Carcinoma Following the Milan Criteria
Cancers · 03.02.2025 · 17 (3) · 507
DOI: 10.3390/cancers17030507 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 03.02.2025. Verfasst von Takashi Kokudo und 1 weiteren Autor:innen. Beteiligte Einrichtung: National Center for Global Health and Medicine, Tokyo 162-8655, Japan. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Since their introduction in the 1990s, the Milan criteria have been the gold standard of indication for liver transplantation (LT) in patients with hepatocellular carcinoma (HCC). Nevertheless, several institutions have reported wider indication criteria for LT with comparable survival outcomes.
Methods
This paper summarizes the recent indications for LT for HCC through a literature review.
Results
There are several criteria expanding the Milan criteria, which can be subdivided into the “based on tumor number and size only”, “based on tumor number and size plus tumor markers”, and “based on tumor differentiation” groups, with the outcomes being comparable to those of patients included within the Milan criteria. Besides the tumor size and number, which are included in the Milan criteria, recent criteria included biomarkers and tumor differentiation. Several retrospective studies have reported microvascular invasion (MVI) as a significant risk factor for postoperative recurrence, highlighting the importance of preoperatively predicting MVI. Several studies attempted to identify preoperative predictive factors for MVI using tumor markers or preoperative imaging findings. Patients with HCC who are LT candidates are often treated while on the waiting list to prevent the progression of HCC or to reduce the measurable disease burden of HCC. The expanding repertoire of chemotherapeutic regiments suitable for patients with HCC should be further investigated.
Conclusions
There are several criteria expanding Milan criteria, with the outcomes being comparable to those of patients included within the Milan criteria.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- National Center for Global Health and Medicine, Tokyo 162-8655, Japan.
Zitieren
APA
Kokudo, T., & Kokudo, N. (2025). Evolving Indications for Liver Transplantation for Hepatocellular Carcinoma Following the Milan Criteria. Cancers, 17(3), 507. https://doi.org/10.3390/cancers17030507
Vancouver
Kokudo T, Kokudo N. Evolving Indications for Liver Transplantation for Hepatocellular Carcinoma Following the Milan Criteria. Cancers. 2025;17(3):507. doi:10.3390/cancers17030507
BibTeX
@article{Kokudo2025,
author = {Kokudo, Takashi and Kokudo, Norihiro},
title = {Evolving Indications for Liver Transplantation for Hepatocellular Carcinoma Following the Milan Criteria},
journal = {Cancers},
year = {2025},
volume = {17},
number = {3},
pages = {507},
doi = {10.3390/cancers17030507}
}
EUVIMED